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Background
 COVID-19 vaccine approval: 
 12/11/2020: the U.S. Food and Drug Administration approved the Pfizer-BioNTech
COVID-19 vaccine for emergency use in adults aged 16 and older¹. 
 12/18/2020: the U.S. Food and Drug Administration approved the Moderna COVID-
19 vaccine for emergency use in adults aged 18 and older¹.
 COVID-19 vaccine perceptions:
 WHO now considers vaccine hesitancy a major threat to public health².
 Survey of US adults reported only 50% of Americans plan to get vaccinated when 
the vaccine is first available and 25% say they will never get it³.
 Concerns around vaccine and development, lack of trust in government, perceived 
benefits of vaccine, and access to vaccinations³.
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Public Health Costs
 COVID-19 Numbers in Vermont as of 1/14/20214: 
 Total cases: 9,573 and rising
 Total deaths from COVID-19: 162 
 BIPOC Vermonters disproportionately impacted5: 
 BIPOC Vermonters represent 6% of Vermont population, but 18% of COVID-19 cases, with 
significantly higher hospitalization rates relative to white population with COVID-19.
 Financial Impact:
 UVM Health Network with fiscal end year loss of $150 million in 2020 due to 
postponement of non-emergent appointments/procedures due to pandemic6.
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Community Perspective
 “I don’t know if I want [the vaccine]. You see all these different things on the 
television—someone dies from COVID, someone has no symptoms, someone 
has a reaction to the shot. I honestly don’t know what to think.”
–Patient at South Burlington Family Medicine practice
 “I haven’t know what to think about the vaccine. I’ve seen a lot of things on 
Facebook about how fast it was made and all the side effects, and I just don’t 
know about the safety. It helps to hear what the doctor thinks about it.” 
–Patient at South Burlington Family Medicine practice
 “I never get the flu shot, and I’ve never had the flu! But I want the COVID 
vaccine, I don’t want to take any chances with COVID at my age.”
–80 year old Patient at South Burlington Family Medicine practice
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Intervention and Methodology
 Part 1: Survey to assess attitudes and concerns regarding the COVID-19 
vaccine (see attached file, survey created by Claudia Russell, MS3) 
 Survey deployed at UVM Family Medicine practice in South Burlington, VT;  
North Country Primary Care in Newport, VT; and Ridgefield Primary Care in 
Ridgefield, CT for adult patients aged 18 years and older
 Participation was voluntary and no identifying information was collected 
 Part 2: Provide informational brochure about the COVID-19 vaccine (see 
attached file, brochure created by Faith Wilson, MS3 and Zeynep Tek, MS3) 
 Brochure provided to all patients who participated. 
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Results
 51 patients participated in the survey, 38 from 
Vermont
 53% from South Burlington Family Practice; 21.6% from 
North Country Primary Care in Newport, VT, and 25.4% 
from Ridgefield Primary Care in Ridgefield, CT
 45.1% male;  54.9% female 
 Ages:  18-29: 2%;   30-49: 21.5%;   50-64: 35.3%;   65-79: 
31.4%;   80+: 9.8%
 78.4% of participants (40 total) plan on getting the 
vaccine when available. 
 17.7% of participants (9 patients) are unsure, while 
only 3.9% (2 patients) do not plan on getting the 
vaccine.
6A






 Other responses written by participants: 
 “I have too many allergies” (3 participants) 
 “I think it was rushed to be made” 
 “I don’t trust vaccines up to 10 years of coming out” 
 From this small sample size of the 11 patients who  
answered “No” or “Unsure”, fear of long term side 
effects and lack of information are the biggest 
contributors to vaccine hesitancy in this 
population, followed by fear of allergic reactions. 
0 1 2 3 4 5 6 7
I don't want it
I don't need it
I worry I will get sick from it
I worry about long term side effect
I need more information about the vaccine
I have already had COVID-19
I don't trust the vaccine's safety
Other
If you are not sure or you do not plan on 




 Many patients who answered “unsure” on the survey verbally reported that felt more confident in the 
vaccine after receiving the pamphlet and discussing with their provider. 
 Limitations: 
 Small sample size: N= 51, a larger sample would have given the study more power.
 Selection bias: All participants were patients with in-person visits at family medicine practices in South 
Burlington and Newport, VT, and Ridgefield, CT. 
 Given that all participants are presenting for care, they may be more health conscious than the general 
population. 
 Additionally, all participants were seen in-person during the COVID-19 pandemic (vs. telemedicine), thus may 
have had different healthcare needs that could not be assessed via video visit, or different attitudes than 
patients presenting for telemedicine. 
 Did not collect information such as race, ethnicity, or level of education:
 Race and ethnicity could be especially important to look at given the inequitable access to healthcare and the 
disproportionate impact of the COVID-19 pandemic on BIPOC Vermonters. 
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Recommendations for future 
interventions/projects
 COVID-19 vaccine perception over time:
 Especially as more information emerges and as vaccines become more widely 
available, how will patient perceptions of the vaccine change?
 Impact of the brochure:
 Did the COVID-19 vaccine impact patients’ perceptions or confidence in the 
vaccine?
 Sources of information: 
 Where are patients getting their information about the vaccine?
 What sources impact their perceptions the most?
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